INVX enters the final days of August with an unusual combination: short sellers retreating sharply, the lending market flush with supply, and a fresh analyst target raise arriving from one of the Street's more closely watched names — all while the stock sits 5% off its weekly high and about 15% below the consensus analyst target.
The most striking development in the positioning data is how quickly shorts have unwound. Short interest dropped 27% in a single session on August 25, pulling the total to roughly 2% of free float — down from around 2.8% where it had been anchored for most of the prior month. That's a decisive move in a matter of days, not a gradual drift. The lending market reflects the same looseness: borrow availability is running above 1,000%, meaning there are more than ten shares available for every one currently borrowed. Cost to borrow is essentially negligible at 0.46%, and the ORTEX short score has fallen from 46 to 40 over the past two weeks — a meaningful easing that ranks in the bottom quarter of the universe on short pressure. This is not a setup that signals residual short-side conviction.
Options positioning tells a mildly different story, though the contrast is modest rather than dramatic. The put/call ratio jumped to 0.18 on August 25 — above its 20-day average of 0.11 — though the z-score of 0.87 keeps it well within normal range. The 52-week PCR high is 0.58, so even this slight uptick in put buying is far from extreme. What it does reflect is a modest pickup in hedging interest after weeks where the ratio ran near its annual lows, a period when call-heavy positioning dominated. The borrow market and the options market are not sending contradictory signals so much as different shades of the same cautious-but-not-alarmed picture.
On the Street, the direction of travel remains constructive, and it got a fresh nudge this week. Citigroup's Scott Gruber lifted his target on INVX to $36 from $35 on August 26 — the second time he has raised it since initiating coverage in May — while keeping a Buy rating. That puts the consensus mean price target at $33.40 against a close of $28.68, implying roughly 16% upside at current levels. Barclays sits at the cautious end of the group with an Equal-Weight and a $27 target, nudged up from $26 two weeks ago. EPS momentum scores rank in the high-70s percentile, forward estimates are tracking well above year-ago levels, and the EV/EBITDA multiple has edged lower over the past month to 8.9x — a modest compression that keeps valuation from looking stretched given the growth rate. The bull case rests on execution in a recovering oilfield services cycle; the Barclays hesitance reflects uncertainty about whether that cycle sustains.
The ownership picture carries the most notable data point of the past month. Amberjack Capital Partners — which held more than 25% of shares as recently as early August — offloaded a combined 4.8 million shares on August 10 at $28.71, reducing its stake materially. The transactions spanned multiple tranches but were concentrated in a single day and totalled roughly $117 million. The 90-day insider net position reflects that sale as a net disposal of around 5 million shares worth $144 million. Separately, a divisional president trimmed 10,000 shares at $30 on August 4, shortly after the Q2 earnings print. Notably, BlackRock added 430,000 shares through July, and Dimensional Fund Advisors took on 228,000 — suggesting institutional buyers absorbed at least part of the Amberjack supply. Whether that supply overhang is now cleared or partially carried by the market is the question worth watching.
The next scheduled earnings event is November 4. The two most recent quarters each produced single-day gains of 7–13% on results, suggesting the stock tends to move meaningfully on prints rather than absorb them quietly. With short interest now at a multi-month low, the borrow pool flush, and the Amberjack distribution largely behind it, the setup heading into Q3 results will be shaped less by technical short-side dynamics and more by whether the energy services cycle — and INVX's progress within it — holds pace through the autumn.
See the live data behind this article on ORTEX.
Open INVX on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
